< 1 minute read
Sep. 17, 2021

BAY1161909: A Pro-Mitotic Selective MPS1 Kinase Inhibitor

BAY1161909

pro-mitotic selective MPS1 kinase inhibitor dev. paused for 2nd candidate (BAY1217389) from 2M cmpd biochem. HTS and SBDD J. Med. Chem., Apr. 27, 2020 Bayer AG, Berlin, DE

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in